Archive: Company News
Company News: Curetis to Present Data from Unyvero LRT U.S. FDA Clinical Trial at ASM Microbe

– U.S. data set complemented by recent clinical study data from European hospital
Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that significant clinical data updates on its Unyvero System and P55 / LRT cartridge for the diagnosis of pneumonia and lower respiratory tract infections will be presented at ASM Microbe 2017, being held June 1-5 in New Orleans, LA.